Company Announcements

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 _______________________________________________________________________
|1 |Details of the person discharging managerial responsibilities /     |
|  |person closely associated                                           |
|__|____________________________________________________________________|
|a)|Name                           |Nicola Shepherd                     |
|__|_______________________________|____________________________________|
|2 |Reason for the notification                                         |
|__|____________________________________________________________________|
|a)|Position/status                |Non-executive Director              |
|__|_______________________________|____________________________________|
|b)|Initial notification /Amendment|Initial notification                |
|__|_______________________________|____________________________________|
|3 |Details of the issuer, emission allowance market participant,       |
|  |auction platform, auctioneer or auction monitor                     |
|__|____________________________________________________________________|
|a)|Name                           |The Biotech Growth Trust PLC        |
|__|_______________________________|____________________________________|
|b)|LEI                            |549300Z41EP32MI2DN29                |
|__|_______________________________|____________________________________|
|  |Details of the transaction(s): section to be repeated for (i) each  |
|4 |type of instrument; (ii) each type of transaction; (iii) each date; |
|  |and (iv) each place where transactions have been conducted          |
|__|____________________________________________________________________|
|  |Description of the financial   |Ordinary 25p shares                 |
|a)|instrument, type of instrument |                                    |
|  |                               |GB0000385517                        |
|  |Identification code            |                                    |
|__|_______________________________|____________________________________|
|b)|Nature of the transaction      |Acquisition of Shares               |
|__|_______________________________|____________________________________|
|  |                               | __________________________________ |
|  |                               ||Price(s)               |Volume(s) ||
|c)|Price(s) and volume(s)         ||_______________________|__________||
|  |                               ||770.932 pence per share|500 shares||
|  |                               ||_______________________|__________||
|__|_______________________________|____________________________________|
|  |Aggregated information         |                                    |
|  |                               |500 ordinary 25p shares             |
|d)|- Aggregated volume            |                                    |
|  |                               |770.932 pence per share             |
|  |- Price                        |                                    |
|__|_______________________________|____________________________________|
|e)|Date of the transaction        |11 June 2025                        |
|__|_______________________________|____________________________________|
|f)|Place of the transaction       |London Stock Exchange (XLON)        |
|__|_______________________________|____________________________________|

 

Name of authorised official of issuer responsible for making notification:

 

Katherine Manson, for and on behalf of Frostrow Capital LLP

Company Secretary to The Biotech Growth Trust PLC